Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

299

To be discontinued: 2 (1%)
Discontinued: 297 (99%)
Reversed: 0 (0%)

Late reports

361 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2021-01-07 2021-02-12 131093
CINQAIR 10MG SOLUTION Resolved 2020-05-08 2020-09-03 114421
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2019-06-27 2019-08-29 87665
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-06-24 2021-07-09 141469
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2023-04-27 2023-06-09 190671
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2023-06-16 2023-08-18 195121
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2019-11-07 2020-05-29 98188
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-01-15 2021-05-06 131691
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-02-05 2021-04-29 133457
DOCETAXEL INJECTION 20MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1680
DOCETAXEL INJECTION 80MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1688
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2021-04-21 2021-05-20 137890
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2018-06-22 2018-10-11 52823
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2023-06-20 2023-10-19 195806
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-06-18 2020-06-25 118253
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2023-01-12 2023-10-06 180891
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2023-06-16 2023-07-05 195219
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2025-01-30 2025-04-24 249210
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2025-01-30 2025-03-20 249213
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-01-20 2022-04-21 153156

Showing 361 to 380 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2025-03-20 2025-03-20 253165
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2024-10-11 2024-10-11 240081
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2021-02-12 2021-02-12 133908
TEVA-NAPROXEN 250MG TABLET Discontinued 2017-06-27 2017-06-27 14055
TEVA-NAPROXEN SODIUM DS 550MG TABLET Discontinued 2019-04-11 2019-04-11 81350
TEVA-NORFLOXACIN 400MG TABLET Discontinued 2018-10-19 2018-10-19 65013
TEVA-NYSTATIN 100000UNIT SUSPENSION Discontinued 2018-10-12 2018-10-12 63946
TEVA-NYSTATIN 100000UNIT SUSPENSION Discontinued 2018-10-12 2018-10-12 63949
TEVA-NYSTATIN 100000UNIT CREAM Discontinued 2020-07-10 2020-07-10 120056
TEVA-OXYBUTYNIN 5MG TABLET Discontinued 2024-06-28 2024-06-29 231586
TEVA-OXYBUTYNIN 5MG TABLET Discontinued 2024-10-11 2024-10-11 240078
TEVA-PANTOPRAZOLE MAGNESIUM 40MG TABLET (DELAYED-RELEASE) Discontinued 2021-02-12 2021-02-12 133891
TEVA-PAROXETINE 10MG TABLET Discontinued 2025-03-20 2025-03-20 253182
TEVA-PAROXETINE 10MG TABLET Discontinued 2019-04-11 2019-04-11 81313
TEVA-PAROXETINE 20MG TABLET Discontinued 2025-03-20 2025-03-20 253160
TEVA-PAROXETINE 30MG TABLET Discontinued 2019-12-09 2019-12-09 100540
TEVA-PAROXETINE 20MG TABLET Discontinued 2019-12-09 2019-12-09 100547
TEVA-PAROXETINE 10MG TABLET Discontinued 2020-02-21 2020-02-21 106898
TEVA-PAROXETINE 30MG TABLET Discontinued 2020-02-21 2020-02-21 106901
TEVA-PIOGLITAZONE 45MG TABLET Discontinued 2018-10-19 2018-10-19 65033

Showing 221 to 240 of 299